Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


What COVID Spotlight Means For Pharma – In Their Own Words

Observers Weigh In On The Impact Pandemic Response Will Have On Industry's Reputation

Executive Summary

Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem. 

The biopharmaceutical industry has more commonly been seen as a villian in recent years, but it has played a heroic role in responding to the COVID-19 pandemic – rising to meet challenges from research and development to manufacturing, all in unprecedented timelines with new levels of collaboration and virtually unrestricted budgets. As new treatments reach patients and vaccines get closer, will there be a goodwill benefit for the industry? Scrip spoke with several industry execs and outside observers about the potential for pharma to reset its reputation. (Also see "Can Pharma Rebuild Its Reputation? COVID-19 Means A Big Responsibility, And Opportunity" - Scrip, 30 Oct, 2020.)  Below are some of their responses. 

Infographic: Will COVID Spotlight Help Pharma's Reputation Shine?

Downloadable PDF version

Related Content


Key Documents

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts